parkinson's disease	is a	neurodegenerative disorder
parkinson's disease	presents with	tremor
parkinson's disease	presents with	bradykinesia
parkinson's disease	presents with	rigidity
parkinson's disease	presents with	postural instability
parkinson's disease	involves	dopaminergic neuron loss
parkinson's disease	involves	nigrostriatal pathway
parkinson's disease	associated with	Lewy bodies
parkinson's disease	associated with	alpha-synuclein aggregates
parkinson's disease	diagnosed by	clinical assessment
parkinson's disease	diagnosed with	DaT scan
levodopa	is a	dopamine precursor
parkinson's disease	treated with	levodopa
levodopa	crosses	blood-brain barrier
carbidopa-levodopa	is a	combination therapy
parkinson's disease	treated with	carbidopa-levodopa
levodopa	provides	motor symptom relief
levodopa	can cause	dyskinesia
dyskinesia	is a	motor complication
dopamine agonist	used for	motor symptom relief
pramipexole	is a	dopamine agonist
ropiniriole	is a	dopamine agonist
rotigotine	is a	dopamine agonist
dopamine agonist	may cause	impulse control disorders
impulse control disorder	is adverse effect of	dopamine agonist
MAO-B inhibitors	used for	motor fluctuations
selegiline	is a	MAO-B inhibitor
rasagiline	is a	MAO-B inhibitor
parkinson's disease	treated with	MAO-B inhibitors
COMT inhibitors	used for	levodopa durability
entacapone	is a	COMT inhibitor
tolcapone	is a	COMT inhibitor
parkinson's disease	treated with	COMT inhibitors
amantadine	used for	dyskinesia relief
amantadine	is a	NMDA receptor antagonist
amantadine	reduces	dyskinesia
deep brain stimulation	improves	motor symptoms
deep brain stimulation	targets	subthalamic nucleus
subthalamic nucleus	is a	brain structure
globus pallidus interna	is a	brain structure
parkinson's disease	treated with	physical therapy
parkinson's disease	managed with	exercise
exercise	improves	gait
physical therapy	improves	mobility
parkinson's disease	associated with	constipation
parkinson's disease	associated with	sleep disturbance
parkinson's disease	associated with	REM sleep behavior disorder
parkinson's disease	associated with	hyposmia
hyposmia	is an early non-motor symptom of	parkinson's disease
parkinson's disease	associated with	depression
parkinson's disease	associated with	anxiety
parkinson's disease	associated with	cognitive impairment
parkinson's disease	associated with	dementia
parkinson's disease	associated with	psychosis
parkinson's disease	increases	fall risk
parkinson's disease	causes	orthostatic hypotension
orthostatic hypotension	is a non-motor symptom of	parkinson's disease
dementia	occurs with	advanced parkinson's disease
parkinson's disease	increases	caregiver burden
parkinson's disease	increases	healthcare utilization
parkinson's disease	increases	mortality risk
parkinson's disease	demonstrates	disease progression
parkinson's disease	progresses with	time
dyskinesia	is a	complication of levodopa therapy
levodopa therapy	associated with	wearing-off phenomenon
wearing-off phenomenon	occurs with	levodopa
levodopa	leads to	motor fluctuations
motor fluctuations	are common with	long-term levodopa
long-term levodopa therapy	leads to	dyskinesia
deep brain stimulation	improves	quality of life
subthalamic nucleus	is targeted by	deep brain stimulation
carbidopa	inhibits	aromatic L-amino acid decarboxylase
carbidopa	reduces	peripheral levodopa side effects
levodopa	requires	peripheral decarboxylase inhibition
family history	increases	parkinson's disease risk
pesticide exposure	is a risk factor for	parkinson's disease
age	is a risk factor for	parkinson's disease
male sex	is a risk factor for	parkinson's disease
smoking	inversely associated with	parkinson's disease
caffeine intake	associated with	reduced parkinson's disease risk
alpha-synuclein	accumulates in	Lewy bodies
Lewy bodies	are composed of	alpha-synuclein
nigrostriatal degeneration	causes	motor symptoms
DAT uptake	decreases in	parkinson's disease
DaT scan	helps	diagnosis of parkinson's disease
olfactory dysfunction	precedes	motor symptoms in parkinson's disease
constipation	is a non-motor symptom of	parkinson's disease
sleep disturbance	is a non-motor symptom of	parkinson's disease
REM sleep behavior disorder	is a non-motor precursor of	parkinson's disease
hypophonia	occurs with	parkinson's disease
dysphagia	occurs with	parkinson's disease
speech impairment	occurs with	parkinson's disease
gait disturbance	is present in	parkinson's disease
dementia	may appear in	advanced parkinson's disease
parkinson's disease	requires	multidisciplinary care
levodopa	interacts with	vitamin B6
vitamin B6	reduces	levodopa efficacy
parkinson's disease	may require	caregiver support
parkinson's disease	is	progressive neurodegenerative condition
